Search Results - "DeHoratius, Raphael J."

Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age by Tesser, John, Kafka, Shelly, DeHoratius, Raphael J, Xu, Stephen, Hsia, Elizabeth C, Turkiewicz, Anthony

“…To evaluate the safety and efficacy of intravenous golimumab + methotrexate (MTX) in patients with active rheumatoid arthritis (RA) aged < 65 years and those ≥…”
Get full text

Patient Perspectives on Intravenous Biologics for Rheumatologic Disease by Grisanti, Lucas, Kwiatkowski, Alysia, Dyrda, Peter, Field, Ellen, Grisanti, Joseph, Hatem, James, Dehoratius, Raphael J., Gaylis, Norman

“…Objective Two surveys were conducted with patients with rheumatologic diseases to evaluate perceptions of different routes of administration (intravenous [IV]…”
Get full text

Rosai-Dorfman disease in a patient with systemic lupus erythematosus by KAUR, Primal P, BIRBE, Ruth C, DEHORATIUS, Raphael J

“…Rosai-Dorfman disease (RDD), also known as sinus histocytosis with massive lymphadenopathy, is a clinically benign, frequently chronic, painless…”
Get full text

Outcomes of infliximab dose escalation in patients with rheumatoid arthritis by Cohen, Stanley B., Kremer, Joel M., Dandreo, Kimberly J., Reed, George W., Magner, Robert, Shan, Ying, Kafka, Shelly, DeHoratius, Raphael J., Ellis, Lorie, Parenti, Dennis

“…Introduction Dose escalation of infliximab in both primary and secondary nonresponders is widely reported; however, the usefulness of dose escalation has been…”
Get full text

Clinical response to golimumab in rheumatoid arthritis patients who were receiving etanercept or adalimumab: results of a multicenter active treatment study by Huffstutter, Joseph E., Kafka, Shelly, Brent, Lawrence H., Matucci-Cerinic, Marco, Tang, Kezhen L., Chevrier, Marc, Sprabery, Trev, DeHoratius, Raphael J.

“…Objective: Evaluate the efficacy and safety of subcutaneous (SC) golimumab + methotrexate (MTX) in patients with active rheumatoid arthritis (RA) despite…”
Get full text

Septic arthritis caused by Actinobacillus ureae in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor-alpha therapy by KAUR, Primal P, DERK, Chris T, CHATTERJI, Melanie, DEHORATIUS, Raphael J

“…Actinobacillus ureae, formerly known as Pasteurella ureae, is a rare human pathogen. We describe a case of septic arthritis and abscess formation caused by…”
Get full text

Satisfaction with Subcutaneous Golimumab and its Auto-Injector among Rheumatoid Arthritis Patients with Inadequate Response to Adalimumab or Etanercept by Dehoratius, Raphael J., Brent, Lawrence H., Curtis, Jeffrey R., Ellis, Lorie A, Tang, Kezhen L.

“…Background Patient perceptions of treatment success, including satisfaction/preference, may complement clinical efficacy assessments. Objective Our objective…”
Get full text

The Effectiveness of Intravenous Golimumab Administered Directly After Infliximab in Rheumatoid Arthritis Patients by Bray, Vance J., Broadwell, Aaron, Baraf, Herbert S. B., Black, Shawn, Brady, Brenna L., Tkacz, Joseph, Yarngo, Lorraine, DeHoratius, Raphael J.

“…Purpose For patients with rheumatoid arthritis (RA) who do not respond or lose response to anti-tumor necrosis factor (TNF) biologics, switching to a different…”
Get full text

Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature by Kovacs, Birgit, Lafferty, Thomas L, Brent, Lawrence H, DeHoratius, Raphael J

“…OBJECTIVE To give a comprehensive review of transverse myelopathy (TM), a rare but serious condition reported in 1–2% of patients with systemic lupus…”
Get full text

Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab by Ellis, Lorie A, Malangone-Monaco, Elisabetta, Varker, Helen, Stetsovsky, Diana, Kubacki, Maureen, DeHoratius, Raphael J, Kafka, Shelly

“…The objectives of this study were to evaluate and compare treatment patterns and infusion-related health care resource expenditures for rheumatoid arthritis…”
Get full text

Exploring the generalist-subspecialist interface in internal medicine by Linzer, Mark, Myerburg, Robert J, Kutner, Jean S, Wilcox, C Mel, Oddone, Eugene, DeHoratius, Raphael J, Naccarelli, Gerald V

Get more information

Systemic lupus erythematosus and acute pancreatitis: a case series by Derk, Chris T, DeHoratius, Raphael J

“…The aim of this study was to evaluate whether corticosteroid use is the etiological agent in acute pancreatitis in patients with systemic lupus erythematosus,…”
Get full text

Musculoskeletal manifestations of endocrine disorders by Jacobs-Kosmin, Dana, DeHoratius, Raphael J

“…PURPOSE OF REVIEWMuch of our education about endocrine disorders focuses on their diagnosis and treatment. Although the musculoskeletal manifestations of…”
Get full text

Calciphylaxis: An important imitator of cutaneous vasculitis by Jacobs‐Kosmin, Dana, DeHoratius, Raphael J.

Get full text

Pregnancy Outcomes in Female Renal Recipients: A Comparison of Systemic Lupus Erythematosus With Other Diagnoses by McGrory, Carolyn H., McCloskey, Laura J., DeHoratius, Raphael J., Dunn, Stephen R., Moritz, Michael J., Armenti, Vincent T.

“…This study compares pregnancy outcomes in systemic lupus erythematosus (SLE) patients post renal transplant with recipients with other primary diagnoses,…”
Get full text

Ex nihilo nihil fit by DeHoratius, Raphael J.

Get full text

Plasmapheresis in systemic lupus erythematosus: a cautionary note by Schlansky, R, DeHoratius, R J, Pincus, T, Tung, K S

“…Plasmapheresis was used as the sole treatment modality in 4 patients with systemic lupus erythematosus. The presence of circulating immune complexes in this…”
Get more information

PREGNANCY OUTCOMES IN FEMALE RENAL RECIPIENTS: A COMPARISON OF SYSTEMIC LUPUS ERYTHEMATOSUS TO OTHER DIAGNOSES: Abstract# 683 by McGrory, Carolyn H., McCloskey, Laura J., DeHoratius, Raphael J., Dunn, Stephen R., Moritz, Michael J., Armenti, Vincent T.

Get full text

Immunofluorescent and immunologic studies of rheumatoid lung by DeHoratius, R J, Abruzzo, J L, Williams, Jr, R C

Get more information

LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: Results from a randomized, double‐blind, placebo‐controlled study by Alarcón‐Segovia, Donato, Tumlin, James A., Furie, Richard A., McKay, James D., Cardiel, Mario H., Strand, Vibeke, Bagin, Robert G., Linnik, Matthew D., Hepburn, Bonnie

“…Objective To determine whether LJP 394 delays or prevents renal flare in patients with systemic lupus erythematosus (SLE) and a history of renal disease…”
Get full text